Video

What Is the Role of Direct Oral Anticoagulants in Patient Care?

Conference|ASHP Midyear Clinical Meeting and Exhibition - American Society of Health System Pharmacists Midyear Clinical Meeting and Exhibition

William Dager, PharmD, BCPS, FASHP, FCCP, FCCM, MCCM, discusses the use of direct oral anticoagulants.

William Dager, PharmD, BCPS, FASHP, FCCP, FCCM, MCCM, discusses the use of direct oral anticoagulants.

Related Videos
Image credit: Photo18@desing | stock.dobe.com
Related Content
CAR T-cell therapy in microbiome -- Image credit: LASZLO | stock.adobe.com
April 28th 2025

Investigating the Impact of the Microbiome on CAR T-Cell Therapy Outcomes

Alana Hippensteele, Lead Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
AACR 2025: Off-the-Shelf CAR NK Therapy SENTI-202 Shows Potential for Complete Remission in R/R AML
April 27th 2025

AACR 2025: Off-the-Shelf CAR NK Therapy SENTI-202 Shows Potential for Complete Remission in R/R AML

Alana Hippensteele, Lead Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
AACR 2025: Oral Investigational Agent Zoldonrasib Elicits Objective Responses in Patients With KRAS G12D-Mutated NSCLC
April 27th 2025

AACR 2025: Oral Investigational Agent Zoldonrasib Elicits Objective Responses in Patients With KRAS G12D-Mutated NSCLC

Alana Hippensteele, Lead Editor
Sickle cell anemia: painful crises, anemia, infections. Treatment focuses on managing symptoms and preventing complications.
April 26th 2025

Hydroxyurea Produces Long-Term Clinical Benefits in Pediatrics With Sickle Cell Anemia

Luke Halpern, Assistant Editor